Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Quadrivalent Human Papillomavirus Recombinant Vaccine

Quadrivalent Human Papillomavirus Recombinant Vaccine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Quadrivalent Human Papillomavirus Recombinant Vaccine

12 trials tracked of Quadrivalent Human Papillomavirus Recombinant Vaccine: 6 in phase 3 or 4 and 1 with published results. The most-cited published study has 6 citations.

12Trials tracked
6Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 6 Phase 2 3 Phase 1 2 Other / NA 1
  1. Phase 3 Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial Completed · 6 cited
  2. Phase 3 GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046) Completed
  3. Phase 3 Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029) Completed
  4. Phase 3 Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041) Completed
  5. Phase 3 An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) Completed
  6. Phase 3 A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) Completed
Show 6 more trials
  1. Phase 2 V501 Efficacy Study in Women Aged 18 to 26 (V501-027) Completed
  2. Phase 2 Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males Completed
  3. Phase 2 V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028) Completed
  4. Phase 1 Vaccine Therapy in Preventing HPV in HIV-Positive Women in India Completed
  5. Phase 1 An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035) Completed
  6. N/A The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.